Innate Pharma (Euronext Paris: FR0010331421 – IPH) announces today the outcome of its annual general meeting (“AGM”) which took place on May 25, 2010, in Marseilles, France.

A number of 26,673,253 votes were expressed out of a total of 37,759,766 shares with voting rights, representing a quorum of 71.0%. All resolutions were voted in accordance with the management’s recommendations. Details of the votes are available on Innate Pharma’s website, investors section.

The Company also announces the following changes in the composition of its management and governance bodies